Pharmacokinetics, Pharmacodynamics and Clinical data update from phase 0/1 trial for BDTX-1535 in recurrent glioblastoma patients with EGFR alterations.

silevertinib (BDTX-1535) - Black Diamond Therap

N. Sanai; Y. Umemura; V. Karapetyan; T. Margaryan; D. Huttenlocher; B. Pham; J. Harmon; A. Hong; W. Yoo; A. Tien; A. Tovmasyan; S. Mehta

Oct 12, 2025